Immorta Bio Demonstrates Dramatic Lifespan Extension in Aging Mouse Models; Research Accepted for Presentation at AAI's IMMUNOLOGY2026 - PR Newswire March 11, 2026 Summary generation failed due to API error. Read the full article below. Source: prnewswire.com Share Related on HealthspanWire Alchemab Therapeutics names Ulrich Wendt chief business officer Mar 18, 2026 Cellino appoints Ed Tekeian as chief operating officer Mar 18, 2026 Cognition Therapeutics reports Zervimesine slows NPI decline in DLB Mar 18, 2026 Anavex reports blarcamesine benefits in Parkinson’s disease model Mar 18, 2026 Autophagy as a Double Edged Sword in Aging Mar 18, 2026
